The legacy of Viagra and its originator, copyright, presents a complex picture for cautious investors. While the iconic drug initially produced enormous revenues , its protection has lapsed , leading to rival alternatives flooding the landscape . This reduction in value presents a real hurdle for copyright and any company considering a significant